Back

Impact of anatomical factors and implantation position on defibrillation threshold in extravascular implantable cardioverter-defibrillator

31 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Evolving implantable cardioverter-defibrillator therapy: from novel technologies to risk stratification and patient impact Implantable Cardioverter-Defibrillator (ICD) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Haruka Matsuura

National Cerebral & Cardiovascular Center, Suita (Japan)

7 More presentations in this session

Presentation thumbnail
Mortality and appropriate therapies in patients with HFrEF undergoing EPS before ICD implantation
Doctor N. Teodorovich (Rehovot, IL)
Abstract Slides Video
Presentation thumbnail
Risks of appropriate implantable cardioverter defibrillator therapy and cardiac hospitalization are increased around device-detected atrial high-rate episodes longer than 6 minutes
Doctor N. Norgaard (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Videoscopic-guided retrosternal access for extravascular icd implantation: a technique to enhance safety and lead positioning
Doctor D. Nair (Jonesboro, US)
Abstract Slides Video
Presentation thumbnail
Psychological impact of implantable cardiac devices: reassurance or distress?
Doctor K. Mavromoustakou (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Real-world outcomes of subcutaneous ICD implants: a single-centre experience
Doctor J. Dixon (Exeter, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Evolving implantable cardioverter-defibrillator therapy: from novel technologies to risk stratification and patient impact

The Event

Event poster

ESC Congress 2026

31 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Bridging two extravascular defibrillator systems: comparative outcomes of extravascular ICD versus subcutaneous ICD - a single-center experience
13 April 2026
thumbnail
Congress Presentation
Optimisation of decrementing evoked potential mapping for functional substrate identification in ischaemic ventricular tachycardia ablation
17 April 2023
thumbnail
Congress Presentation
Defibrillation threshold testing in hypertrophic cardiomyopathy: acute outcomes and long-term follow-up
13 April 2026
thumbnail
Congress Presentation
Right ventricular function as a predictor of appropriate therapy of implantable cardioverter defibrillator
25 April 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources